title: Ototopical antifungals and otomycosis: a review.
abstract: There has been an increase in the prevalence of otomycosis in recent years. This has been linked to the extensive use of antibiotic eardrops. Treatment of otomycosis is challenging, and requires a close follow-up. We present a review of the literature on otomycosis, the topical antifungals most commonly used, and discuss their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.
authors.affiliation: McGill Auditory Sciences Laboratory, McGill University, Montreal, Qc., Canada H3H1P3.
authors.forename: Raymundo
authors.initials: R
authors.lastname: Munguia
authors.forename: Sam J
authors.initials: SJ
authors.lastname: Daniel
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001228:Aspergillosis / Q000150:complications; D002177:Candidiasis / Q000150:complications; D004427:Ear Diseases / Q000188:drug therapy* / Q000382:microbiology*; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents